Healthcare fund managers caution against getting caught up in Covid-19 vaccine hype
Gilead Sciences has taken investors on a rollercoaster ride as it trials a treatment for the coronavirus
Gilead Sciences has taken investors on a rollercoaster ride as it trials a treatment for the coronavirus
‘When we could not prove that remote working could work, people were afraid to try it’
Five investors mull the events shaping portfolios over the past week
Continuing our regular series of how investment experts are dealing with the coronavirus fallout
Portfolio Adviser looks at the tomes keeping investors informed and entertained during the Covid-19 outbreak
Charles Stanley among investment firms leading the way with volunteer force of staff and clients
Middle of the month saw buying frenzy as evidence showed pandemic outbreak was slowing
Premier Diversified Growth manager hedged two-thirds of the portfolio before it became expensive to do so
FTSE 100 companies spent £136bn buying back their own shares from 2010 to 2019
Woodford Equity Income liquidation and virus create stumbling blocks to gearing reduction and portfolio rebalancing
The key events for UK wealth managers for the week starting 4 May
Five investors mull the events shaping portfolios over the past week